L17.9 Kilder
Antirevmatiske legemidler
Furst DE, Keystone EC, Fleischmann R et al. Updated consensus on biological agents for the treatment of rheumatic diseases, 2009. Ann Rheum Dis 2010;67 (Supl 1):iii2-29
Veileder i svangerskap og revmatiske sykdommer. Nasjonal kompetansetjeneste for svangerskap og revmatiske sykdommer (NKSR). Revmatologisk avdeling. St. Olavs Hospital. Oppdatert mars 2018. nksr.no
Denosumab
Boquete-Castro A, Gómez-Moreno G, Calvo-Guirado JL, Aguilar-Salvatierra A, Delgado-Ruiz RA. Denosumab and osteonecrosis of the jaw. A systematic analysis of events reported in clinical trials. Clin Oral Implants Res. 2016 Mar; 27(3): 367-75. doi: 10.1111/clr.12556. Epub 2015 Feb 2.
FDA Warning and precautions. Ref. ID: 3324257. https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125320s094lbl.pdf
Zoledronat
AU Grey A, Bolland MJ, Wattie D, Horne A, Gamble G, Reid IR. The Antiresorptive Effects of a Single Dose of Zoledronate Persist for Two Years: A Randomized, Placebo-Controlled Trial in Osteopenic Postmenopausal Women. J Clin Endocrinol Metab. 2009;94(2):538. Epub 2008 Dec 2.